SAN DIEGO--(BUSINESS WIRE)--
Retrophin, Inc. (NASDAQ:RTRX) today announced it will report first
quarter 2015 financial results on Monday, May 11, 2015 after the close
of the U.S. financial markets. The Company will host a conference call
and webcast to review the financial and operational results and provide
a general business update at 4:30 p.m. ET.
|
|
|
Conference Call Information
|
|
|
|
Date:
|
|
|
|
|
Monday, May 11, 2015
|
|
Time:
|
|
|
|
|
4:30 p.m. ET
|
|
Dial-in numbers:
|
|
|
|
|
+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)
|
|
Confirmation code:
|
|
|
|
|
36758378
|
|
Live webcast:
|
|
|
|
|
www.retrophin.com
in the "Events & Presentations" section of the "Investors" page
|
|
|
A replay of the call will be available 7:30 p.m. ET, May 11, 2015 to
11:59 p.m., May 18, 2015. The replay number is 855-859-2056 (U.S.) or
404-537-3406 (International), confirmation code 36758378.
About Retrophin
Retrophin is a pharmaceutical company focused on the development,
acquisition and commercialization of drugs for the treatment of serious,
catastrophic or rare diseases for which there are currently no viable
options for patients. The Company's approved products include Chenodal®,
Cholbam™, and Thiola®, and its pipeline includes compounds for several
catastrophic diseases, including focal segmental glomerulosclerosis
(FSGS), pantothenate kinase-associated neurodegeneration (PKAN),
infantile spasms, nephrotic syndrome and others. For additional
information, please visit www.retrophin.com.
Retrophin, Inc.
Chris Cline, CFA, 646-564-3680
Manager,
Investor Relations
IR@retrophin.com
Source: Retrophin, Inc.
News Provided by Acquire Media